Patent · US Active

Clay-based hemostatic agents

US10086106B2 · kind B2 · utility

5Cited by
128References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 11, 2018
Grant dateOct 2, 2018
Priority date
Expiry dateApr 11, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61L2400/16
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

A hemostatic device for promoting the clotting of blood includes a gauze substrate, a clay material disposed on the gauze substrate, and also a polyol such as glycerol or the like disposed on the gauze substrate to bind the clay material. When the device is used to treat a bleeding wound, at least a portion of the clay material comes into contact with blood emanating from the wound to cause the clotting. A bandage that can be applied to a bleeding wound to promote the clotting of blood includes a flexible substrate and a gauze substrate mounted thereon. The gauze substrate includes a clay material and a polyol. A hemostatic sponge also includes a gauze substrate and a dispersion of hemostatic material and a polyol on a first surface of the substrate.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.